MANE
NYSE ·

Veradermics Inc

Mid-Cap Stocks
$109.51
-6.35 (-5.48%)
As of Jul 26, 11:09 PM ET ·
MANE News1 articles
Veradermics Soars After Hair-Loss Drug Meets Trial Goals
Veradermics shares jumped 40% after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial, with patients seeing significant hair count increases.
Markets